Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers.

Tulunay OE, Hecht SS, Carmella SG, Zhang Y, Lemmonds C, Murphy S, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1283-6.

2.

Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.

Anderson KE, Carmella SG, Ye M, Bliss RL, Le C, Murphy L, Hecht SS.

J Natl Cancer Inst. 2001 Mar 7;93(5):378-81.

PMID:
11238699
3.

Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.

Carmella SG, Borukhova A, Akerkar SA, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):113-20.

4.

Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.

Hecht SS, Carmella SG, Chen M, Dor Koch JF, Miller AT, Murphy SE, Jensen JA, Zimmerman CL, Hatsukami DK.

Cancer Res. 1999 Feb 1;59(3):590-6.

5.

Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children.

Hecht SS, Ye M, Carmella SG, Fredrickson A, Adgate JL, Greaves IA, Church TR, Ryan AD, Mongin SJ, Sexton K.

Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1109-16.

6.

Uptake of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by Moldovan children.

Stepanov I, Hecht SS, Duca G, Mardari I.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):7-11.

7.

The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.

Vogel RI, Carmella SG, Stepanov I, Hatsukami DK, Hecht SS.

Biomarkers. 2011 Sep;16(6):491-7. doi: 10.3109/1354750X.2011.598565. Epub 2011 Aug 3.

8.

Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons.

Anderson KE, Kliris J, Murphy L, Carmella SG, Han S, Link C, Bliss RL, Puumala S, Murphy SE, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1544-6.

9.

Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).

Muscat JE, Djordjevic MV, Colosimo S, Stellman SD, Richie JP Jr.

Cancer. 2005 Apr 1;103(7):1420-6.

10.

Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.

Benowitz N, Goniewicz ML, Eisner MD, Lazcano-Ponce E, Zielinska-Danch W, Koszowski B, Sobczak A, Havel C, Jacob P 3rd.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2795-800. doi: 10.1158/1055-9965.EPI-10-0497. Epub 2010 Aug 30.

11.

Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.

Derby KS, Cuthrell K, Caberto C, Carmella S, Murphy SE, Hecht SS, Le Marchand L.

Int J Cancer. 2009 Nov 15;125(10):2418-24. doi: 10.1002/ijc.24585.

12.

Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn.

Florek E, Piekoszewski W, Basior A, Merritt AT, Mazela J, Lechowicz W, Kornacka MK, Kramer L.

J Physiol Pharmacol. 2011 Jun;62(3):377-83.

13.

Metabolites of a tobacco-specific lung carcinogen in children exposed to secondhand or thirdhand tobacco smoke in their homes.

Thomas JL, Guo H, Carmella SG, Balbo S, Han S, Davis A, Yoder A, Murphy SE, An LC, Ahluwalia JS, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1213-21. doi: 10.1158/1055-9965.EPI-10-1027. Epub 2011 Apr 5.

14.

Children's exposure to secondhand and thirdhand smoke carcinogens and toxicants in homes of hookah smokers.

Kassem NO, Daffa RM, Liles S, Jackson SR, Kassem NO, Younis MA, Mehta S, Chen M, Jacob P 3rd, Carmella SG, Chatfield DA, Benowitz NL, Matt GE, Hecht SS, Hovell MF.

Nicotine Tob Res. 2014 Jul;16(7):961-75. doi: 10.1093/ntr/ntu016. Epub 2014 Mar 3.

15.

4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides in the urine of infants exposed to environmental tobacco smoke.

Hecht SS, Carmella SG, Le KA, Murphy SE, Boettcher AJ, Le C, Koopmeiners J, An L, Hennrikus DJ.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):988-92.

16.

Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.

Richie JP Jr, Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 1997 Oct;6(10):783-90.

17.

A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke.

Hecht SS, Carmella SG, Murphy SE, Akerkar S, Brunnemann KD, Hoffmann D.

N Engl J Med. 1993 Nov 18;329(21):1543-6.

18.

Tobacco smoke exposure in nonsmoking hospitality workers before and after a state smoking ban.

Jensen JA, Schillo BA, Moilanen MM, Lindgren BR, Murphy S, Carmella S, Hecht SS, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1016-21. doi: 10.1158/1055-9965.EPI-09-0969. Epub 2010 Mar 30.

19.

Urinary biomarkers to assess exposure of cats to environmental tobacco smoke.

McNiel EA, Carmella SG, Heath LA, Bliss RL, Le KA, Hecht SS.

Am J Vet Res. 2007 Apr;68(4):349-53.

PMID:
17397288
20.

Supplemental Content

Support Center